Plasmacytosis is a common immune signature in patients with MMN and CIDP and responds to treatment with IVIg.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Neuroimmunology

• Publication date

  2015-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jneuroim.2014.11.012PMID 25595253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES Neuropathy with Onion Bulb Formations and Pure Motor Manifestations

  2014cited by this paper
• Recovery of the T-cell repertoire in CIDP by IV immunoglobulins

  2013cited by this paper
• Immunopathogenic mechanisms of systemic autoimmune disease.

  2013cited by this paper
• CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy

  2012cited by this paper
• Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies

  2012cited by this paper
• Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies

  2012influential reference
• Immune Pathogenesis and Treatment of Multifocal Motor Neuropathy

  2012cited by this paper
• TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase.

  2011cited by this paper
• The Long‐Term Survival of Plasma Cells

  2011cited by this paper
• B cells undergo unique compartmentalized redistribution in multiple sclerosis.

  2011cited by this paper
• Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica

  2011cited by this paper
• Expression and function of the inhibitory Fcγ‐receptor in CIDP

  2011cited by this paper
• Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy

  2010cited by this paper
• AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

  2010cited by this paper
• IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN.

  2010influential reference
• European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision

  2010influential reference
• IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes.

  2010cited by this paper
• European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First Revision

  2010cited by this paper
• B cells in the pathogenesis and treatment of rheumatoid arthritis

  2010cited by this paper
• Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg).

  2010cited by this paper
• European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision

  2010influential reference
• IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy

  2010influential reference
• Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition

  2010cited by this paper
• Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease.

  2010cited by this paper
• Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

  2009cited by this paper
• Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica

  2008cited by this paper
• Prominent Plasmacytosis Following Intravenous Immunoglobulin Correlates with Clinical Improvement in Guillain-Barré Syndrome

  2008cited by this paper
• Influence of impaired T‐ and B‐cell compartments on efficacy of IVIg in dysimmune neuropathies

  2007cited by this paper
• From bench to bedside—experimental rationale for immune-specific therapies in the inflamed peripheral nerve

  2007cited by this paper
• Intravenous Immunoglobulin and Cytokines

  2007cited by this paper
• Anti-GM1 Antibodies Cause Complement-Mediated Disruption of Sodium Channel Clusters in Peripheral Motor Nerve Fibers

  2007cited by this paper
• Challenges and Controversies in Autoantibodies Associated with Systemic Rheumatic Diseases

  2007cited by this paper
• BAFF, a New Target for Intravenous Immunoglobulin in Autoimmunity and Cancer

  2007cited by this paper
• European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy *

  2006cited by this paper
• Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy

  2006cited by this paper
• Chronic inflammatory demyelinating polyneuropathy – update on pathogenesis, diagnostic criteria and therapy

  2005cited by this paper
• Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.

  2005cited by this paper
• CD16+CD57– Natural Killer Cells in Multifocal Motor Neuropathy

  2005cited by this paper
• Multifocal motor neuropathy.

  2005cited by this paper
• Multifocal Motor Neuropathy: Pathologic Alterations at the Site of Conduction Block

  2004cited by this paper
• Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome.

  2002cited by this paper
• Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy

  2001cited by this paper
• Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus1

  2000cited by this paper
• Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy.

  2000influential reference
• Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients

  2000cited by this paper
• The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy

  1999cited by this paper
• The distribution of CD1 molecules in inflammatory neuropathy.

  1998cited by this paper
• Multifocal motor neuropathy

  1997influential reference
• Motor nerve biopsy studies in motor neuropathy and motor neuron disease

  1997cited by this paper
• Inflammatory infiltrates in sural nerve biopsies in Guillain‐Barré syndrome and chronic inflammatory demyelinating neuropathy

  1996cited by this paper
• Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases.

  1995cited by this paper
• Chronic inflammatory demyelinating polyneuropathy: Histological and immunopathological studies on biopsied sural nerves

  1994cited by this paper

• Systematic literature review of published cases of reactive plasmacytosis in peripheral blood and bone marrow

  2024cites this paper
• The gut microbiome in intravenous immunoglobulin‐treated chronic inflammatory demyelinating polyneuropathy

  2023cites this paper
• Immunomodulatory effects of intravenous and subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: An observational study

  2023cites this paper
• Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes

  2023cites this paper
• Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice

  2021cites this paper
• IVIg‐induced plasmablasts in patients with Guillain‐Barré syndrome

  2018cites this paper
• What is new in 2015 in dysimmune neuropathies?

  2016cites this paper
• Autoimmune inflammatory neuropathies: updates in pathogenesis, diagnosis, and treatment.

  2015cites this paper
• Human immune globulin infusion in the management of multifocal motor neuropathy

  2015cites this paper